Biohit HealthCare in brief

Biohit HealthCare is a globally operating biotechnology company that develops, manufactures and markets diagnostic tests and analysis systems.

Our products are used by research and healthcare worldwide.

• Established in 1988 by Professor Osmo Suovaniemi
• Business area: Diagnostics
• Headquartered in Finland, Helsinki.
• Subsidiary is located in  the UK
• Production plant ís located in Finland.
• Biohit's products are sold by many distributors around the world.
• Biohit Plc's share (BIOBV) is quoted on NASDAQ OMX Helsinki since June1999, Small cap/Healthcare.
  

Innovations and patents

Biohit HealthCare's operations are based on a goal-oriented and long-term innovation and patenting strategy. Biohit works with scientific communities to produce new technologies, products and services based on research results and innovations that can be used to develop safe and cost-effective diagnostic tests for the early detection and prevention of diseases of the gastrointestinal tract.

Diagnostics

Biohit HealthCare has products and analysis systems for the early diagnosis of gastrointestinal diseases, such as the blood-sample based GastroPanel examinations for the diagnosis of stomach illnesses and associated risks, quick tests for the diagnosis of lactose intolerance and Helicobacter pylori infection in connection with gastroscopy, and the ColonView examination for the early detection of fecal occult intestinal bleeding (faecal occult blood) that indicates a risk of colorectal cancer. The Acetium innovation was developed to reduce carcinogenic acetaldehyde in the gastrointestinal tract. The key objective of the diagnostics business is to prevent diseases of the gastrointestinal tract.

Biohit Group worldwide

The Biohit Group employs around 35 people in four countries. The company is headquartered in Helsinki, Finland, and has subsidiary in the UK. Additionally, Biohit's products are sold by many distributors around the world.

Biohit Plc. on the stock exchange

Biohit's series B share (BIOBV) is quoted on NASDAQ OMX Helsinki, Small cap/Healthcare since 1999. More information about the share and financials is available in the Investors section of this site.